Jason Kolbert

Maxim Group analyst Jason Kolbert weighed in today with some commentary on Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) after a U.S.

Maxim analysts Jason Kolbert and Jason Mccarthy weighed in today on the Israeli pharmaceutical giant Teva Pharmaceutical Industries Ltd (NYSE:TEVA), California based gene therapy company Avalanche Biotechnologies Inc (NASDAQ:AAVL), and gene therapy …

Cytori Therapeutics Inc (NASDAQ:CYTX) has been maintained as a Buy at Maxim Group by research analyst Jason Kolbert in a recent report released today. …

Maxim Group analyst Jason Kolbert came out with a research report on AEterna Zentaris Inc. (USA) (NASDAQ:AEZS), after visiting with management in South Carolina and reviewing the company …

Maxim Group analyst Jason Kolbert came out with a favorable report on Medivation Inc (NASDAQ:MDVN), raising the price target to $168 (from $155), …

A research report was issued today by Maxim Group analyst Jason Kolbert on Novabay Pharmaceuticals, Inc. (NYSE:NBY), after the company announced  receipt of 510(k) clearance from the …

Maxim’s healthcare analyst Jason Kolbert weighed in today with a favorable report on Galena Biopharma Inc (NASDAQ:GALE), after the company reported the presentation of two abstracts at …

IsoRay, Inc. (NYSEMKT:ISR) shares soared as much as 94 percent yesterday, after the company released data in an online publication regarding the first major peer reviewed …

Jason Kolbert of Maxim Group rates stocks in the biotechnology sector and he’s ranked #2811 out of 3602 analysts on TipRanks. Yesterday, Kolbert made two news …

The first quarter of 2015 has come to a close and companies are still releasing earnings reports. Let’s look back and see which …